Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS

NCT00744536

Conditions: Angiogenesis, Bone Marrow Diseases, Chronic Disease, +12 more
Locations: Sunnybrook Health Sciences Centre, Odette Cancer Center Toronto, Ontario, Canada

View Trial Details

Completed

Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)

NCT00687323

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes

NCT01305135

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: CHU de Haut-Lévèque Pessac, Bordeaux - Pessac, France

CHU d'Amiens Amiens, France

CHU d'Angers Angers, France

Hôpital de la cote basque Bayonne, France

View all 32 locations

View Trial Details

Completed

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00241358

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT01440374

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +11 more
Locations: Novartis Investigative Site Phoenix, Arizona, United States

Novartis Investigative Site Hot Springs, Arkansas, United States

Novartis Investigative Site Jonesboro, Arkansas, United States

Novartis Investigative Site Los Angeles, California, United States

View all 120 locations

View Trial Details

Completed

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

NCT01158118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +31 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

NCT00481143

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +8 more
Locations: Novartis Investigative Site Berlin, Germany

View Trial Details

Completed

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

NCT01323920

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions